{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:16Z","timestamp":1786118896793,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/wco.0b013e32830e2774","type":"journal-article","created":{"date-parts":[[2008,9,3]],"date-time":"2008-09-03T07:04:35Z","timestamp":1220425475000},"page":"590-595","source":"Crossref","is-referenced-by-count":56,"title":["Drug-induced myopathies"],"prefix":"10.1097","volume":"21","author":[{"given":"Thomas","family":"Klopstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210206","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"R2-13-20210206","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"Am J Cardiol"},{"key":"R3-13-20210206","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systematic review","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"key":"R4-13-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/BOR.0b013e328010c559","article-title":"Myotoxicity associated with lipid-lowering drugs","volume":"19","author":"Baer","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"R5-13-20210206","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000100908","article-title":"Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program","volume":"107","author":"Shepherd","year":"2007","journal-title":"Cardiology"},{"key":"R7-13-20210206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/path.2018","article-title":"Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia","volume":"210","author":"Draeger","year":"2006","journal-title":"J Pathol"},{"key":"R8-13-20210206","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1073\/pnas.87.22.8931","article-title":"Lovastatin decreases coenzyme Q levels in humans","volume":"87","author":"Folkers","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-13-20210206","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R10-13-20210206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2003.08.013","article-title":"Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats","volume":"194","author":"Schaefer","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"R11-13-20210206","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"P\u00e4iv\u00e4","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R12-13-20210206","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch Neurol"},{"key":"R13-13-20210206","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am J Cardiol"},{"key":"R14-13-20210206","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","article-title":"Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia","volume":"100","author":"Young","year":"2007","journal-title":"Am J Cardiol"},{"key":"R15-13-20210206","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01213011-200506000-00007","article-title":"Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage","volume":"15","author":"Wilke","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R16-13-20210206","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd2423","article-title":"Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges","volume":"6","author":"Wilke","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"R17-13-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"R18-13-20210206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-6-7","article-title":"Genetic determinants of statin intolerance","volume":"6","author":"Oh","year":"2007","journal-title":"Lipids Health Dis"},{"key":"R19-13-20210206","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000101287","article-title":"Statins provoking MELAS syndrome. A case report","volume":"57","author":"Thomas","year":"2007","journal-title":"Eur Neurol"},{"key":"R20-13-20210206","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/446975a","article-title":"When good drugs go bad","volume":"446","author":"Giacomini","year":"2007","journal-title":"Nature"},{"key":"R21-13-20210206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S0317167100007514","article-title":"A neuromuscular approach to statin-related myotoxicity","volume":"35","author":"Baker","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"R22-13-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat Med"},{"key":"R23-13-20210206","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-133-3-200008010-00010","article-title":"Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases","volume":"133","author":"Miller","year":"2000","journal-title":"Ann Intern Med"},{"key":"R24-13-20210206","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"C\u00f4t\u00e9","year":"2002","journal-title":"N Engl J Med"},{"key":"R25-13-20210206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/17425255.3.4.583","article-title":"The role of cytochrome P450 in antiretroviral drug interactions","volume":"3","author":"Walubo","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R26-13-20210206","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/135965350701200711","article-title":"Pharmacokinetics and pharmacodynamics of combined use of lopinavir\/ritonavir and rosuvastatin in HIV-infected patients","volume":"12","author":"van der Lee","year":"2007","journal-title":"Antivir Ther"},{"key":"R27-13-20210206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/BOR.0b013e3282f1fea7","article-title":"Rheumatic manifestations of human immunodeficiency virus infection","volume":"20","author":"Louthrenoo","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"R28-13-20210206","first-page":"651","article-title":"Polymyositis associated with HIV infection during immune restoration induced by highly active antiretroviral therapy","volume":"22","author":"Calza","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R29-13-20210206","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0560.2007.00767.x","article-title":"Terbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositis","volume":"35","author":"Magro","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R30-13-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review","volume":"21","author":"No\u00ebl","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R31-13-20210206","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/ncprheum0700","article-title":"Tendinopathy \u2013 from basic science to treatment","volume":"4","author":"Riley","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R32-13-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1752-1947-1-55","article-title":"Fluoroquinolone-associated tendinopathy: a case report","volume":"1","author":"Ng","year":"2007","journal-title":"J Med Case Reports"},{"key":"R33-13-20210206","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00002018-200629100-00006","article-title":"Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study","volume":"29","author":"Corrao","year":"2006","journal-title":"Drug Saf"},{"key":"R34-13-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1345\/aph.1E285","article-title":"Acute rhabdomyolysis associated with ofloxacin\/levofloxacin therapy","volume":"39","author":"Hsiao","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R35-13-20210206","first-page":"1405","article-title":"Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment","volume":"28","author":"Guis","year":"2001","journal-title":"J Rheumatol"},{"key":"R36-13-20210206","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00228-003-0688-x","article-title":"A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin","volume":"59","author":"Petitjeans","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"R37-13-20210206","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/00000542-199404000-00029","article-title":"Local anesthetic myotoxicity: a case and review","volume":"80","author":"Hogan","year":"1994","journal-title":"Anesthesiology"},{"key":"R38-13-20210206","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bja\/aeg029","article-title":"Anaesthesia-related diplopia after cataract surgery","volume":"90","author":"G\u00f3mez-Arnau","year":"2003","journal-title":"Br J Anaesth"},{"key":"R39-13-20210206","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.annfar.2007.09.007","article-title":"Diplopia complicating peribulbar anesthesia for cataract surgery and early use of MRI (French)","volume":"26","author":"Dupont","year":"2007","journal-title":"Ann Fr Anesth Reanim"},{"key":"R40-13-20210206","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcrs.2003.09.064","article-title":"Persistent diplopia after retrobulbar anesthesia","volume":"30","author":"Han","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"R41-13-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/bjo.2006.110619","article-title":"Bupivacaine injection of eye muscles to treat strabismus","volume":"91","author":"Scott","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R42-13-20210206","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.bpb.0000111028.02081.2e","article-title":"Treatment of severe iatrogenic quadriceps retraction in children","volume":"13","author":"Burnei","year":"2004","journal-title":"J Pediatr Orthop B"},{"key":"R43-13-20210206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1302\/0301-620X.67B1.3968153","article-title":"Triceps contracture caused by injections. A report of 11 cases","volume":"67","author":"Babhulkar","year":"1985","journal-title":"J Bone Joint Surg Br"},{"key":"R45-13-20210206","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1346-8138.2007.00402.x-i1","article-title":"Nicolau syndrome aggravated by cold application after i.m. diclofenac","volume":"35","author":"Senel","year":"2008","journal-title":"J Dermatol"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e32830e2774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:04:38Z","timestamp":1786035878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-200810000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e32830e2774","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}